Pharmaceutical Manufacturing Handbook: Production and

REFERENCES 641
60. Collens , W. S. , and Goldzeiher , M. A. ( 1932 ), Absorption of insulin by nasal mucous
membranes , Proc. Soc. Exp. Biol. Med. , 29 , 756 .
61. Major , R. H. ( 1935 ), The intranasal application of insulin , J. Lab. Clin. Med. , 21 , 278 .
62. Major , R. H. ( 1936 ), The intranasal application of insulin , Am. J. Med. Sci. , 192 , 257 .
63. Gordon , G. S. , Moses , A. C. , Silver , R. D. , Flier , J. S. , and Carey , M. C. ( 1985 ), Nasal
absorption of insulin: Enhancement by hydrophobic bile salts , Proc. Natl. Acad. Sci. USA ,
82 , 7419 – 7423 .
64. Morimoto , K. , Morisaka , K. , and Kamada , A. ( 1985 ), Enhancement of nasal absorption
of insulin and calcitonin using polyacrylic acid gel , J. Pharm. Pharmacol. , 37 , 134 – 136 .
65. Pillion , D. J. , Atchison , J. A. , Gargiulo , C. , Wang , R. X. , Wang , P. , and Meezan , E. ( 1994 ),
Insulin delivery in nosedrops: New formulations containing alkylglycosides , Endocrinology
, 135 , 2386 – 2391 .
66. Pillion , D. J. , Ahsan , F. , Arnold , J. J. , Balusubramanian , B. M. , Piraner , O. , and Meezan ,
E. ( 2002 ), Synthetic long - chain alkyl maltosides and alkyl sucrose esters as enhancers
of nasal insulin absorption , J. Pharm. Sci. , 91 , 1456 – 1462 .
67. Ahsan , F. , Arnold , J. J. , Meezan , E. , and Pillion , D. J. ( 2003 ), Sucrose cocoate, a component
of cosmetic preparations, enhances nasal and ocular peptide absorption , Int. J.
Pharm. , 251 , 195 – 203 .
68. Illum , L. , Jabbal - Gill , I. , Hinchcliffe , M. , Fisher , A. N. , and Davis , S. S. ( 2001 ), Chitosan
as a novel nasal delivery system for vaccines , Adv. Drug Deliv. Rev. , 51 , 81 – 96 .
69. Illum , L. ( 1992 ), Nasal delivery of peptides, factors affecting nasal absorption , in Topics
in Pharmaceutical Sciences , Medpharm Scientifi c , Stuttgart , p. 71 .
70. Illum , L. , Farraj , N. F. , and Davis , S. S. ( 1994 ), Chitosan as a novel nasal delivery system
for peptide drugs , Pharm. Res. , 11 , 1186 – 1189 .
71. Fern á ndez - Urrusuno , R. , Calvo , P. , Remu ñ á n - L ó pez , C. , Vila - Jato , J. L. , and Alonso ,
M. J. ( 1999 ), Enhancement of nasal absorption of insulin using chitosan nanoparticles ,
Pharm. Res. , 16 , 1576 – 1581 .
72. Dyer , A. M. , Hinchcliffe , M. , Watts , P. , Castile , J. , Jabbal - Gill , I. , Nankervis , R. , Smith , A. ,
and Illum , L. ( 2002 ), Nasal delivery of insulin using novel chitosan based formulations:
A comparative study in two animal models between simple chitosan formulations and
chitosan nanoparticles , Pharm. Res. , 19 , 998 – 1008 .
73. Yu , S. , Zhao , Y. , Wu , F. , Zhang , X. , L ü , W. , Zhang , H. , and Zhang , Q. ( 2004 ), Nasal
insulin delivery in the chitosan solution: In vitro and in vivo studies , Int. J. Pharm. , 281 ,
11 – 23 .
74. Varshosaz , J. , Sadrai , H. , and Alingari , R. ( 2004 ), Nasal delivery of insulin using chitosan
microspheres , J. Microencapsul. , 21 , 761 – 774 .
75. Varshosaz , J. , Sadrai , H. , and Heidari , A. ( 2006 ), Nasal delivery of insulin using bioadhesive
chitosan gels , Drug Deliv. , 13 , 31 – 38 .
76. Pontiroli , A. E. , Alberetto , M. , and Pozza , G. ( 1985 ), Intranasal calcitonin and plasma
calcium concentrations in normal subjects , Br. Med. J. , 290 , 1390 – 1391 .
77. Morimoto , K. , Morisaka , K. , and Kamada , A. ( 1985 ), Enhancement of nasal absorption
of insulin and calcitonin using polyacrylic acid gel , J. Pharm. Pharmacol. , 37 , 134 –
136 .
78. Morimoto , K. , Akatsuchi , H. , Aikawa , R. , Morishita , M. , and Morisaka , K. ( 1984 ),
Enhanced rectal absorption of [Asu1, 7] - eel calcitonin in rats using polyacrylic acid
aqueous gel base , J. Pharm Sci. , 73 , 1366 – 1368 .
79. Lee , K. C. , Tak , K. K. , Park , M. O. , Lee , J. T. , Woo , B. H. , Yoo , S. D. , Lee , H. S. , and DeLuca ,
P. P. ( 1999 ), Preparation and characterization of polyethylene - glycol - modifi ed salmon
calcitonins , Pharm. Dev. Tech. , 4 , 269 – 275 .